Literature DB >> 3031170

Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production.

R S Blumberg, T Paradis, R Byington, W Henle, M S Hirsch, R T Schooley.   

Abstract

We investigated Epstein-Barr virus (EBV)-specific T cell responses in homosexual men with, and at risk for, AIDS. We studied healthy laboratory workers, healthy homosexual men, and patients with AIDS-related complex or AIDS. The cytotoxic activity, absolute number of T4 lymphocytes, and interleukin-2 (IL-2) production decreased, whereas the relative number of Ia+ lymphocytes increased with the extent of infection with the human immunodeficiency virus (HIV). Cytotoxic activity correlated positively with the number of T4 lymphocytes (r = .56, P less than .001) and the amount of IL-2 produced (r = .47, P less than .01) but not with interferon production. Recombinant IL-2, but not gamma interferon, could restore cytotoxic T cell activity to control levels in patients with early HIV infection. EBV-specific serological studies paralleled the T lymphocyte investigations. The increased EBV activity observed in progressive HIV infection may be related to a diminution in the auto-reactive population of the T4 lymphocyte subset and may be amenable to IL-2 reconstitution.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031170     DOI: 10.1093/infdis/155.5.877

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia.

Authors:  J Becker; U Leser; M Marschall; A Langford; W Jilg; H Gelderblom; P Reichart; H Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes.

Authors:  L Musey; Y Ding; J Cao; J Lee; C Galloway; A Yuen; K R Jerome; M J McElrath
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.

Authors:  M J Kersten; M R Klein; A M Holwerda; F Miedema; M H van Oers
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus.

Authors:  M A Rahman; L A Kingsley; R W Atchison; S Belle; M C Breinig; M Ho; C R Rinaldo
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

5.  Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Authors:  Jianhong Cao; John McNevin; Sarah Holte; Lisa Fink; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

6.  Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.

Authors:  P Möller; Y Sun; T Dorbic; S Alijagic; A Makki; K Jurgovsky; M Schroff; B M Henz; B Wittig; D Schadendorf
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.